Role of a Novel Secreted Protein Tyrosine Kinase in Development
新型分泌蛋白酪氨酸激酶在发育中的作用
基本信息
- 批准号:8679884
- 负责人:
- 金额:$ 29.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-09 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AreaAtherosclerosisBiological ModelsCartilageCellsDataData SetDevelopmentDiseaseEmbryoEmbryonic DevelopmentEnvironmentEventExtracellular MatrixExtracellular Matrix ProteinsFibrosisLeadLocationMatrix MetalloproteinasesMorphogenesisNeoplasm MetastasisPathogenesisPathologyPathway interactionsPatternPeptide Signal SequencesPhosphoproteinsPhosphorylationPhosphotransferasesProtein Tyrosine KinaseProteinsPublishingRanaRegulationReportingRoleStructureTissuesTyrosineTyrosine PhosphorylationWorkXenopusbasecraniofacialextracellularin vivointerestnovelpublic health relevanceresearch studytooltumor
项目摘要
DESCRIPTION (provided by applicant): The microenvironment in which cells reside in tissues, the extracellular matrix (ECM), is increasingly recognized as a major regulator of embryonic morphogenesis. We propose to use the Xenopus embryo as a model system to study a novel mechanism of regulation of ECM, the tyrosine phosphorylation of secreted proteins. In our preliminary experiments, we have identified a protein tyrosine kinase that, unlike
any previously known tyrosine kinase, is synthesized directly into the secretory pathway, and which phosphorylates extracellular matrix proteins. Our preliminary data indicate that this novel kinase as a key role in early craniofacial patterning. The activity and location of this kinase provides the first explanation for a large body of published phosphoproteomic work reporting conserved tyrosine phosphorylations in ECM proteins secreted via the canonical signal peptide pathway. We plan to use frog embryos to study the function of this secreted tyrosine kinase in early craniofacial morphogenesis, and identify and characterize tyrosine phosphorylated substrates in an in vivo context. These studies will provide the basis for an entirely new area of study, the reversible regulation of secreted proteins by tyrosine phosphorylation during embryogenesis. Dynamic regulation and remodeling of ECM is also central to a wide range of disease pathologies (e.g. tumor metastasis, fibrosis, atherosclerosis), and therefore the regulation of ECM proteins by tyrosine phosphorylation is likely to also have important implications for the modulation of disease pathogenesis.
描述(由申请人提供):细胞驻留在组织中的微环境,即细胞外基质(ECM),越来越多地被认为是胚胎形态发生的主要调节因子。我们建议使用非洲爪蟾胚胎作为一个模型系统来研究一种新的机制,ECM的分泌蛋白的酪氨酸磷酸化的调节。在我们的初步实验中,我们已经确定了一种蛋白酪氨酸激酶,
任何先前已知的酪氨酸激酶直接合成到分泌途径中,并使细胞外基质蛋白磷酸化。我们的初步数据表明,这种新的激酶作为一个关键作用,在早期颅面图案。该激酶的活性和位置为大量已发表的磷酸蛋白质组学工作提供了第一个解释,这些工作报告了通过经典信号肽途径分泌的ECM蛋白中保守的酪氨酸磷酸化。我们计划使用青蛙胚胎来研究这种分泌的酪氨酸激酶在早期颅面形态发生中的功能,并在体内环境中识别和表征酪氨酸磷酸化底物。这些研究将为一个全新的研究领域提供基础,即胚胎发生过程中酪氨酸磷酸化对分泌蛋白的可逆调节。ECM的动态调节和重塑也是广泛的疾病病理学(例如肿瘤转移、纤维化、动脉粥样硬化)的核心,因此通过酪氨酸磷酸化调节ECM蛋白可能也对疾病发病机制的调节具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MALCOLM R. WHITMAN其他文献
MALCOLM R. WHITMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MALCOLM R. WHITMAN', 18)}}的其他基金
Role of a Novel Secreted Protein Tyrosine Kinase in Development
新型分泌蛋白酪氨酸激酶在发育中的作用
- 批准号:
8836523 - 财政年份:2014
- 资助金额:
$ 29.66万 - 项目类别:
MECHANISM OF ACTION OF HALOFUGINONE AS A NOVEL THERAPEUTIC
卤常酮作为新型治疗药物的作用机制
- 批准号:
8438495 - 财政年份:2010
- 资助金额:
$ 29.66万 - 项目类别:
MECHANISM OF ACTION OF HALOFUGINONE AS A NOVEL THERAPEUTIC
卤常酮作为新型治疗药物的作用机制
- 批准号:
8228147 - 财政年份:2010
- 资助金额:
$ 29.66万 - 项目类别:
MECHANISM OF ACTION OF HALOFUGINONE AS A NOVEL THERAPEUTIC
卤常酮作为新型治疗药物的作用机制
- 批准号:
7767129 - 财政年份:2010
- 资助金额:
$ 29.66万 - 项目类别:
MECHANISM OF ACTION OF HALOFUGINONE AS A NOVEL THERAPEUTIC
卤常酮作为新型治疗药物的作用机制
- 批准号:
8053284 - 财政年份:2010
- 资助金额:
$ 29.66万 - 项目类别:
Regulation of Xenopus Embryonic Development by TGFbeta Superfamily Ligands and SM
TGFbeta 超家族配体和 SM 对非洲爪蟾胚胎发育的调节
- 批准号:
8064547 - 财政年份:2010
- 资助金额:
$ 29.66万 - 项目类别:
ROLE OF MAMALIAN FASTS IN EMBRYONIC TGF BETA SIGNALING
哺乳动物禁食在胚胎 TGF Beta 信号转导中的作用
- 批准号:
6564679 - 财政年份:2001
- 资助金额:
$ 29.66万 - 项目类别:
ROLE OF MAMALIAN FASTS IN EMBRYONIC TGF BETA SIGNALING
哺乳动物禁食在胚胎 TGF Beta 信号转导中的作用
- 批准号:
6108522 - 财政年份:1999
- 资助金额:
$ 29.66万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 29.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 29.66万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 29.66万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 29.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 29.66万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 29.66万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 29.66万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 29.66万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 29.66万 - 项目类别: